ATNX - Athenex Inc.'s (ATNX) CEO Johnson Lau on Q1 2022 Results - Earnings Call Transcript

Athenex, Inc. (ATNX) Q1 2022 Earnings Conference Call May 10, 2022, 08:00 AM ET Company Participants Caileigh Dougherty - Investor Relations Johnson Lau - Chief Executive Officer Daniel Lang - President, Athenex Cell Therapy Jeffrey Yordon - Chief Operating Officer Joe Annoni - Chief Financial Officer Kurt Gunter - Chief Medical Officer, Cell Therapy and Head of Regulatory Affairs Conference Call Participants Kevin DeGeeter - Oppenheimer & Co. Robyn Karnauskas - Truist Securities Jonathan Chang - SVB Leerink Yale Jen - Laidlaw & Company Presentation Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2022 Athenex Earnings Conference Call. After the presentation, there will be an opportunity to ask questions. [Operator Instructions] And as a reminder this conference is being recorded. I would now like to hand the conference over to Caileigh Dougherty, Director of Investor Relations. You may begin. Caileigh Dougherty Good morning and thank you

For further details see:

Athenex, Inc.'s (ATNX) CEO Johnson Lau on Q1 2022 Results - Earnings Call Transcript